Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

FGF13 gene changes cause excessive hair growth in a rare condition.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The hydrogel significantly speeds up wound healing and supports skin cell growth.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

DFMO may help control hair growth and treat cancer.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Y-27632 helps hair follicle stem cells grow and keep their abilities.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

Testosterone reduces knee movement, while flutamide and finasteride increase it.